News 16.08.2013

16 August 2013 / 10:15

We kindly inform that the process of scientific review of initial applications within the program STRATEGMED – NCBiR is completed. 28 initial applications were qualified to further proceedings. Kardio-Med Silesia Ltd as one of the consortium partners is qualified for the second stage in two projects:
Project: “The use of medical data tele transmission in order to improve the quality of patient’s life with heart failure and the reduction of the cost of their treatment – Project MONITEL-HF”.
Project: “Strategy development of The Transregional Scientific Network focused on heart stem cell research and their use in the treatment of patients with chronic heart failure – PEGASUS”.

Please also note that recruitment of applications will start no earlier than 5 November, 2013 (open only to applicants whose applications have been pre-qualified for the second stage).

The final verdict of the program STRATEGMED – NCBiR should take place by the end of the first quarter of 2014.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    I consent to the processing of my personal data by Śląski Park Technologii Medycznych Kardio-Med Silesia Sp. z o.o., 10C M. Curie-Skłodowskiej St., 41-800 Zabrze, KRS:0000396540, NIP:6482761515, Regon:242742607, as Data Controler in order to receive a response. I can withdraw my consent by submitting a statement to: The Data Controler has notified me that this consent does not affect the legality of the processing carried out on the basis of consent before its withdrawal.

    The information clause on the details of the processing is available here.

    Supporting partners: